Literature DB >> 22606221

Structural insights into human peroxisome proliferator activated receptor delta (PPAR-delta) selective ligand binding.

Fernanda A H Batista1, Daniela B B Trivella, Amanda Bernardes, Joyce Gratieri, Paulo S L Oliveira, Ana Carolina M Figueira, Paul Webb, Igor Polikarpov.   

Abstract

Peroxisome proliferator activated receptors (PPARs δ, α and γ) are closely related transcription factors that exert distinct effects on fatty acid and glucose metabolism, cardiac disease, inflammatory response and other processes. Several groups developed PPAR subtype specific modulators to trigger desirable effects of particular PPARs without harmful side effects associated with activation of other subtypes. Presently, however, many compounds that bind to one of the PPARs cross-react with others and rational strategies to obtain highly selective PPAR modulators are far from clear. GW0742 is a synthetic ligand that binds PPARδ more than 300-fold more tightly than PPARα or PPARγ but the structural basis of PPARδ:GW0742 interactions and reasons for strong selectivity are not clear. Here we report the crystal structure of the PPARδ:GW0742 complex. Comparisons of the PPARδ:GW0742 complex with published structures of PPARs in complex with α and γ selective agonists and pan agonists suggests that two residues (Val312 and Ile328) in the buried hormone binding pocket play special roles in PPARδ selective binding and experimental and computational analysis of effects of mutations in these residues confirms this and suggests that bulky substituents that line the PPARα and γ ligand binding pockets as structural barriers for GW0742 binding. This analysis suggests general strategies for selective PPARδ ligand design.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22606221      PMCID: PMC3350516          DOI: 10.1371/journal.pone.0033643

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.752


  32 in total

Review 1.  Peroxisome proliferator-activated receptors: nuclear control of metabolism.

Authors:  B Desvergne; W Wahli
Journal:  Endocr Rev       Date:  1999-10       Impact factor: 19.871

Review 2.  Roles of PPARs in health and disease.

Authors:  S Kersten; B Desvergne; W Wahli
Journal:  Nature       Date:  2000-05-25       Impact factor: 49.962

3.  Coot: model-building tools for molecular graphics.

Authors:  Paul Emsley; Kevin Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

4.  Processing of X-ray diffraction data collected in oscillation mode.

Authors:  Z Otwinowski; W Minor
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

Review 5.  Peroxisome proliferator-activated receptor structures: ligand specificity, molecular switch and interactions with regulators.

Authors:  Vincent Zoete; Aurelien Grosdidier; Olivier Michielin
Journal:  Biochim Biophys Acta       Date:  2007-01-18

6.  PHENIX: a comprehensive Python-based system for macromolecular structure solution.

Authors:  Paul D Adams; Pavel V Afonine; Gábor Bunkóczi; Vincent B Chen; Ian W Davis; Nathaniel Echols; Jeffrey J Headd; Li-Wei Hung; Gary J Kapral; Ralf W Grosse-Kunstleve; Airlie J McCoy; Nigel W Moriarty; Robert Oeffner; Randy J Read; David C Richardson; Jane S Richardson; Thomas C Terwilliger; Peter H Zwart
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-01-22

7.  Infrastructure for the life sciences: design and implementation of the UniProt website.

Authors:  Eric Jain; Amos Bairoch; Severine Duvaud; Isabelle Phan; Nicole Redaschi; Baris E Suzek; Maria J Martin; Peter McGarvey; Elisabeth Gasteiger
Journal:  BMC Bioinformatics       Date:  2009-05-08       Impact factor: 3.169

8.  Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma.

Authors:  R T Nolte; G B Wisely; S Westin; J E Cobb; M H Lambert; R Kurokawa; M G Rosenfeld; T M Willson; C K Glass; M V Milburn
Journal:  Nature       Date:  1998-09-10       Impact factor: 49.962

9.  Novel selective small molecule agonists for peroxisome proliferator-activated receptor delta (PPARdelta)--synthesis and biological activity.

Authors:  Marcos L Sznaidman; Curt D Haffner; Patrick R Maloney; Adam Fivush; Esther Chao; Donna Goreham; Michael L Sierra; Christelle LeGrumelec; H Eric Xu; Valerie G Montana; Millard H Lambert; Timothy M Willson; William R Oliver; Daniel D Sternbach
Journal:  Bioorg Med Chem Lett       Date:  2003-05-05       Impact factor: 2.940

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  17 in total

1.  Identification and Molecular Characterization of Peroxisome Proliferator-Activated Receptor δ as a Novel Target for Covalent Modification by 15-Deoxy-Δ12,14-prostaglandin J2.

Authors:  Aravind T Reddy; Sowmya P Lakshmi; Asoka Banno; Raju C Reddy
Journal:  ACS Chem Biol       Date:  2018-11-29       Impact factor: 5.100

Review 2.  Activation of PPARδ: from computer modelling to biological effects.

Authors:  Shirin Kahremany; Ariela Livne; Arie Gruzman; Hanoch Senderowitz; Shlomo Sasson
Journal:  Br J Pharmacol       Date:  2014-12-15       Impact factor: 8.739

3.  Structural basis for specific ligation of the peroxisome proliferator-activated receptor δ.

Authors:  Chyuan-Chuan Wu; Thomas J Baiga; Michael Downes; James J La Clair; Annette R Atkins; Stephane B Richard; Weiwei Fan; Theresa A Stockley-Noel; Marianne E Bowman; Joseph P Noel; Ronald M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-20       Impact factor: 11.205

Review 4.  Bone muscle crosstalk targets muscle regeneration pathway regulated by core circadian transcriptional repressors DEC1 and DEC2.

Authors:  Jeffrey P Gorski; Jeffrey L Price
Journal:  Bonekey Rep       Date:  2016-11-16

5.  Selective PPARδ Modulators Improve Mitochondrial Function: Potential Treatment for Duchenne Muscular Dystrophy (DMD).

Authors:  Bharat Lagu; Arthur F Kluge; Effie Tozzo; Ross Fredenburg; Eric L Bell; Matthew M Goddeeris; Peter Dwyer; Andrew Basinski; Ramesh S Senaiar; Mahaboobi Jaleel; Nirbhay Kumar Tiwari; Sunil K Panigrahi; Narasimha Rao Krishnamurthy; Taisuke Takahashi; Michael A Patane
Journal:  ACS Med Chem Lett       Date:  2018-07-31       Impact factor: 4.345

6.  Perfluoroalkyl Acid Binding with Peroxisome Proliferator-Activated Receptors α, γ, and δ, and Fatty Acid Binding Proteins by Equilibrium Dialysis with a Comparison of Methods.

Authors:  Manoochehr Khazaee; Emerson Christie; Weixiao Cheng; Mandy Michalsen; Jennifer Field; Carla Ng
Journal:  Toxics       Date:  2021-02-26

7.  Parallel Chemistry Approach to Identify Novel Nuclear Receptor Ligands Based on the GW0742 Scaffold.

Authors:  Kelly A Teske; Ganesha Rai; Premchendar Nandhikonda; Preetpal S Sidhu; Belaynesh Feleke; Anton Simeonov; Adam Yasgar; Ajit Jadhav; David J Maloney; Leggy A Arnold
Journal:  ACS Comb Sci       Date:  2017-09-05       Impact factor: 3.903

Review 8.  Integrative and systemic approaches for evaluating PPARβ/δ (PPARD) function.

Authors:  Greta M P Giordano Attianese; Béatrice Desvergne
Journal:  Nucl Recept Signal       Date:  2015-04-27

9.  Misregulation of PPAR Functioning and Its Pathogenic Consequences Associated with Nonalcoholic Fatty Liver Disease in Human Obesity.

Authors:  Luis A Videla; Paulina Pettinelli
Journal:  PPAR Res       Date:  2012-12-09       Impact factor: 4.964

10.  Structure-based virtual screening and discovery of New PPARδ/γ dual agonist and PPARδ and γ agonists.

Authors:  Vinicius G Maltarollo; Marie Togashi; Alessandro S Nascimento; Kathia M Honorio
Journal:  PLoS One       Date:  2015-03-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.